"This funding marks a significant milestone for Modulight Biotherapeutics as we advance our mission to develop light-based therapeutics for the treatments of severe neurological diseases," said Yotam ...
The Zen Parent on MSN
Music Is More Than Just Nice On The Ears—It Can Boost Your Mental Health, Too
If you’re a music lover, you’ve probably felt how listening to your favorite song can boost your mood. It’s not just ...
ClearPoint Neuro, Inc. ( CLPT) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST [Audio Gap] comments made on this call may include statements that are forward-looking within the meaning of ...
Researchers assessed global trends in early-onset Parkinson Disease, focusing on incident cases, prevalence, years lived with disability, and disability-adjusted life years.
The most common prodromal symptom of Parkinson disease among community-dwelling older adults was cognitive deficit, followed by subthreshold parkinsonism, urinary dysfunction, and olfactory ...
Jean-Martin Charcot (1825-1893), the first major international clinical neurologist. In this celebration year, symposia, ...
MeiraGTx Holdings plc stock surges after a major Eli Lilly partnership boosts funding and pipeline. Click for my updated look ...
Oragenics, Inc. , a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today reported key operational, financial, and ...
Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of ...
Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of DirectorsNext-generation GABA-aminotransferase (GABA-AT) ...
The “plausible mechanism” pathway, outlined by Martin Makary and Vinay Prasad, is designed to help accelerate treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback